Literature DB >> 11113956

Analysis of cost data in randomized trials: an application of the non-parametric bootstrap.

J A Barber1, S G Thompson.   

Abstract

Health economic evaluations are now more commonly being included in pragmatic randomized trials. However a variety of methods are being used for the presentation and analysis of the resulting cost data, and in many cases the approaches taken are inappropriate. In order to inform health care policy decisions, analysis needs to focus on arithmetic mean costs, since these will reflect the total cost of treating all patients with the disease. Thus, despite the often highly skewed distribution of cost data, standard non-parametric methods or use of normalizing transformations are not appropriate. Although standard parametric methods of comparing arithmetic means may be robust to non-normality for some data sets, this is not guaranteed. While the randomization test can be used to overcome assumptions of normality, its use for comparing means is still restricted by the need for similarly shaped distributions in the two groups. In this paper we show how the non-parametric bootstrap provides a more flexible alternative for comparing arithmetic mean costs between randomized groups, avoiding the assumptions which limit other methods. Details of several bootstrap methods for hypothesis tests and confidence intervals are described and applied to cost data from two randomized trials. The preferred bootstrap approaches are the bootstrap-t or variance stabilized bootstrap-t and the bias corrected and accelerated percentile methods. We conclude that such bootstrap techniques can be recommended either as a check on the robustness of standard parametric methods, or to provide the primary statistical analysis when making inferences about arithmetic means for moderately sized samples of highly skewed data such as costs.

Entities:  

Mesh:

Year:  2000        PMID: 11113956     DOI: 10.1002/1097-0258(20001215)19:23<3219::aid-sim623>3.0.co;2-p

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  213 in total

Review 1.  How should cost data in pragmatic randomised trials be analysed?

Authors:  S G Thompson; J A Barber
Journal:  BMJ       Date:  2000-04-29

2.  Open access follow up for inflammatory bowel disease. Would have been better to use t test than Mann-Whitney U test.

Authors:  J A Barber; S G Thompson
Journal:  BMJ       Date:  2000-06-24

3.  The economic burden of atherothrombosis in Greece: results from the THESIS study.

Authors:  Nikos Maniadakis; Georgia Kourlaba; Dennis V Cokkinos; Aggeliki Angeli; John Kyriopoulos
Journal:  Eur J Health Econ       Date:  2012-07-10

4.  The active patient role and asthma outcomes in an underserved rural community.

Authors:  Henry N Young; Tonja L Larson; Elizabeth D Cox; Megan A Moreno; Joshua M Thorpe; Neil J MacKinnon
Journal:  J Rural Health       Date:  2013-06-11       Impact factor: 4.333

5.  Intensive case management for severe psychotic illness: is there a general benefit for patients with complex needs? A secondary analysis of the UK700 trial data.

Authors:  Chris Metcalfe; Ian R White; Tim Weaver; Obioha C Ukoumunne; Kate Harvey; Theresa Tattan; Simon G Thompson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-09-15       Impact factor: 4.328

6.  Economic implications of multiple births: inpatient hospital costs in the first 5 years of life.

Authors:  J Henderson; C Hockley; S Petrou; M Goldacre; L Davidson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

Review 7.  Economic evaluations: a new avenue of outcome assessment in spinal disorders.

Authors:  Nicole van der Roer; Norbert Boos; Maurits W van Tulder
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

8.  The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee.

Authors:  Veerle M H Coupé; Cindy Veenhof; Maurits W van Tulder; Joost Dekker; Johannes W J Bijlsma; Cornelia H M Van den Ende
Journal:  Ann Rheum Dis       Date:  2006-07-31       Impact factor: 19.103

9.  Compliance and efficiency before and after implementation of a clinical practice guideline for laryngeal carcinomas.

Authors:  Michel van Agthoven; Hélène A G Heule-Dieleman; Paul P Knegt; Johannes H A M Kaanders; Robert J Baatenburg de Jong; Bernd Kremer; C René Leemans; Henri A M Marres; Johannes J Manni; Johannes A Langendijk; Peter C Levendag; Reina E Tjho-Heslinga; Joseph M A de Jong; Maarten F de Boer; Carin A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-14       Impact factor: 2.503

10.  Randomization-Based Statistical Inference: A Resampling and Simulation Infrastructure.

Authors:  Ivo D Dinov; Selvam Palanimalai; Ashwini Khare; Nicolas Christou
Journal:  Teach Stat       Date:  2018-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.